High-dose HMG-CoA Inhibitor Simvastatin Relapsed CLL
NCT00828282
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
DRUG:
Simvastatin
Sponsor
John Haslip